Biolab introduces new BlueDiver Microarray – Quantrix Technology to diagnose autoimmune diseases

February 18, 2014 2:36 pm

Biolab, the exclusive Biomnis dealer in the Kingdom, recently introduced a state-of-the-art BlueDiver Microarray – Quantrix Technology designed to test for and diagnose an extensive array of rheumatic and autoimmune diseases. Such panels provide internists, rheumatologists, orthopedists and others a powerful tool for the investigation and differential diagnosis of Autoimmune Diseases.

On this occasion, Biolab’s CEO, Dr. Amid Abdelnoor said,” We always strive to introduce new healthcare and medical testing services to the local community, as we feel that it is our role to elevate healthcare service standards within the sector. We also feel that it is our responsibility to help elevate the quality of life enjoyed by our patients, and so we work to improve their health and well being. Consequently, we are committed to maintaining our pioneering position in the field, a goal we achieve through introducing to the market new health and diagnostic services.”

Through its extensive network of branches, a main branch, and other specialized laboratories, Biolab offers patients, physicians, and hospitals advanced medical services and over 700 different medical tests. It is the sole laboratory in the Kingdom that has received the American Joint Commission International “JCI” accreditation as an independent laboratory, along with the European ISO 15189 certificate. It is also certified by Jordan’s Ministry of Health and adopted by the entirety of local banks and insurance companies.